Richter Transformation Lymphoma
3 clinical trials · Condition
◉ Watch Richter Transformation Lymphoma
| Record | Firm | Date |
|---|---|---|
| A Study of Zilovertamab Vedotin (MK-2140) as Monotherapy and in Combination in Participants With Aggressive and Indolent B-cell Malignancies (MK-2140-006) (NCT05458297) | Merck Sharp & Dohme LLC | 2022-07-21 |
| A Study of Zilovertamab Vedotin (MK-2140) (VLS-101) in Participants With Hematologic Malignancies (MK-2140-001) (NCT03833180) | VelosBio Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 2019-03-14 |
Track Richter Transformation Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.